JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Hert, S. G.
Right arrow Articles by Stowe, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Hert, S. G.
Right arrow Articles by Stowe, D. F.
Related Collections
Right arrow Mechanisms
Right arrow Pharmacology

Anesth Analg 2005;100:1584-1593
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000153483.61170.0C


CARDIOVASCULAR ANESTHESIA

Cardioprotection with Volatile Anesthetics: Mechanisms and Clinical Implications

Stefan G. De Hert, MD, PhD*, Franco Turani, MD{dagger}, Sanjiv Mathur, MD{ddagger}, and David F. Stowe, MD, PhD§

*Department of Anesthesiology, University Hospital Antwerp, Edegem, Belgium; {dagger}Department of Anesthesia and Intensive Care, European Hospital, University of Rome Tor Vergata, Rome, Italy; {ddagger}Department of Anesthesia and Critical Care, Sudbury Regional Hospital, Sudbury, Ontario, Canada; §Departments of Anesthesiology and Physiology, The Medical College of Wisconsin, Department of Biomedical Engineering, Marquette University; Research Service, Veterans Affairs Medical Center, Milwaukee, Wisconsin

Address correspondence and reprint requests to Stefan G. De Hert, MD, PhD, Department of Anesthesiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium. Address e-mail to stefan.dehert{at}ua.ac.be.

Cardiac surgery and some noncardiac procedures are associated with a significant risk of perioperative cardiac morbid events. Experimental data indicate that clinical concentrations of volatile general anesthetics protect the myocardium from ischemia and reperfusion injury, as shown by decreased infarct size and a more rapid recovery of contractile function on reperfusion. These anesthetics may also mediate protective effects in other organs, such as the brain and kidney. Recently, a number of reports have indicated that these experimentally observed protective effects may also have clinical implications in cardiac surgery. However, the impact of the use of volatile anesthetics on outcome measures, such as postoperative mortality and recovery in cardiac and noncardiac surgery, is yet to be determined.




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Lorsomradee, S. Cromheecke, S. Lorsomradee, and S. G De Hert
Cardioprotection with Volatile Anesthetics in Cardiac Surgery
Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. S. Pagel
Additive Cardioprotection by Ethanol and Sevoflurane: Are Sarcolemmal KATP Channels Also Involved?
Anesth. Analg., June 1, 2008; 106(6): 1926 - 1926.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Carles, J. Dellamonica, J. Roux, D. Lena, J. Levraut, J. F. Pittet, P. Boileau, and M. Raucoules-Aime
Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia reperfusion
Br. J. Anaesth., January 1, 2008; 100(1): 29 - 35.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. A. Bouwman, R. J. P. Musters, B. J. van Beek-Harmsen, J. J. de Lange, R. R. Lamberts, S. A. Loer, and C. Boer
Sevoflurane-induced cardioprotection depends on PKC-{alpha} activation via production of reactive oxygen species
Br. J. Anaesth., November 1, 2007; 99(5): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. A. Zvara, A. J. Bryant, D. D. Deal, M. P. DeMarco, K. M. Campos, C. M. Mansfield, and M. Tytell
Anesthetic preconditioning with sevoflurane does not protect the spinal cord after an ischemic-reperfusion injury in the rat.
Anesth. Analg., May 1, 2006; 102(5): 1341 - 1347.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. G. De Hert
Volatile Anesthetics and Cardiac Function
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 33 - 42.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
L. G. Kevin, E. Novalija, and D. F. Stowe
Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice
Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.